Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 6
1947 3
1948 11
1949 10
1950 32
1951 155
1952 376
1953 388
1954 339
1955 335
1956 284
1957 221
1958 200
1959 214
1960 218
1961 210
1962 202
1963 156
1964 163
1965 60
1970 1
1973 1
1978 11
1979 37
1980 47
1981 77
1982 79
1983 76
1984 99
1985 80
1986 76
1987 104
1988 96
1989 116
1990 107
1991 101
1992 108
1993 103
1994 125
1995 173
1996 206
1997 189
1998 217
1999 236
2000 245
2001 247
2002 247
2003 279
2004 338
2005 351
2006 379
2007 565
2008 576
2009 800
2010 694
2011 792
2012 749
2013 771
2014 767
2015 833
2016 888
2017 795
2018 782
2019 718
2020 646
2021 439
2022 222
2023 175
2024 120

Search Results

17,928 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH; SELECT Trial Investigators. Lincoff AM, et al. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 37952131 Clinical Trial.
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023.
Tamargo J, Agewall S, Borghi C, Ceconi C, Cerbai E, Dan GA, Ferdinandy P, Grove EL, Rocca B, Magavern E, Sulzgruber P, Semb AG, Sossalla S, Niessner A, Kaski JC, Dobrev D. Tamargo J, et al. Eur Heart J Cardiovasc Pharmacother. 2024 May 4;10(3):219-244. doi: 10.1093/ehjcvp/pvae013. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38379024 Review.
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M; STELLAR Trial Investigators. Hoeper MM, et al. N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6. N Engl J Med. 2023. PMID: 36877098 Clinical Trial.
Wearable Devices in Cardiovascular Medicine.
Hughes A, Shandhi MMH, Master H, Dunn J, Brittain E. Hughes A, et al. Circ Res. 2023 Mar 3;132(5):652-670. doi: 10.1161/CIRCRESAHA.122.322389. Epub 2023 Mar 2. Circ Res. 2023. PMID: 36862812 Free PMC article. Review.
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
Perera D, Clayton T, O'Kane PD, Greenwood JP, Weerackody R, Ryan M, Morgan HP, Dodd M, Evans R, Canter R, Arnold S, Dixon LJ, Edwards RJ, De Silva K, Spratt JC, Conway D, Cotton J, McEntegart M, Chiribiri A, Saramago P, Gershlick A, Shah AM, Clark AL, Petrie MC; REVIVED-BCIS2 Investigators. Perera D, et al. N Engl J Med. 2022 Oct 13;387(15):1351-1360. doi: 10.1056/NEJMoa2206606. Epub 2022 Aug 27. N Engl J Med. 2022. PMID: 36027563 Clinical Trial.
17,928 results
You have reached the last available page of results. Please see the User Guide for more information.